TURIELLO, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 222
EU - Europa 95
AS - Asia 55
SA - Sud America 9
Totale 381
Nazione #
US - Stati Uniti d'America 221
IT - Italia 35
RU - Federazione Russa 28
SG - Singapore 28
VN - Vietnam 15
IE - Irlanda 12
CN - Cina 11
BR - Brasile 9
DE - Germania 8
SE - Svezia 5
AT - Austria 2
LT - Lituania 2
CZ - Repubblica Ceca 1
FI - Finlandia 1
MX - Messico 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 381
Città #
Chandler 76
Princeton 32
Ann Arbor 21
Dong Ket 14
Singapore 13
Dublin 10
Ashburn 8
Wilmington 7
Lessolo 6
Andover 5
Avellino 5
Moscow 5
Jacksonville 4
Roccapiemonte 4
Spin 4
Nuremberg 3
Beijing 2
Boardman 2
Bonn 2
Esslingen am Neckar 2
Guangzhou 2
Huskvarna 2
Napoli 2
Nemoli 2
Redwood City 2
Seattle 2
Shanghai 2
Vilnius 2
Washington 2
Belo Horizonte 1
Brasília 1
Brno 1
Campo Grande 1
Castellammare Di Stabia 1
Council Bluffs 1
Cândido Sales 1
Dalian 1
Dundalk 1
Fairfield 1
Florianópolis 1
Fuzhou 1
Guaratinguetá 1
Hanoi 1
Lajinha 1
Lappeenranta 1
Longford 1
Los Angeles 1
Mexico City 1
Nanjing 1
Naples 1
Norwalk 1
Palhoça 1
Ponta Grossa 1
San Diego 1
Sarno 1
Stockholm 1
Tashkent 1
The Dalles 1
Vienna 1
Voghera 1
Totale 274
Nome #
Adenosine Signaling in the Tumor Microenvironment 67
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients 47
Enzyme activity of circulating CD73 in human serum 45
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents 44
CD73: A Promising Biomarker in Cancer Patients 43
Lack of Ecto-5′-Nucleotidase Protects Sensitized Mice against Allergen Challenge 36
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy 35
Thrombo-Inflammation: A Focus on NTPDase1/CD39 31
Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5′-Nucleotidase (CD73) 30
A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice 17
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial 5
Totale 400
Categoria #
all - tutte 2.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.343


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 0 9 0
2020/202159 0 1 1 0 0 5 7 0 7 4 16 18
2021/202264 0 0 11 1 1 0 0 2 6 8 10 25
2022/2023142 9 13 6 16 13 26 0 27 21 1 4 6
2023/202440 3 6 5 3 3 6 1 3 0 3 0 7
2024/202581 2 0 0 5 3 19 26 7 13 6 0 0
Totale 400